The industry supports the WHO definition but demands regulators distinguish real dangers. They recommend amending criteria to include potency and full hazard assessments. This avoids banning safe ingredients, which protects the industry's existing product portfolios.
Environmental groups lose a precautionary system that bans chemicals based on inherent hazard.